A2 Biotherapeutics, Inc.

A2 Biotherapeutics is committed to developing safe and effective logic-gated cell therapies for patients with solid tumors. Currently, we do not offer access to our investigational therapies outside of clinical trials. Participation in our ongoing clinical trials is the most appropriate way for patients to access our investigational medicines at this stage of development.